Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy

被引:16
作者
Wang, FX
Kimura, T
Nishihara, K
Yoshimura, K
Koito, A
Matsushita, S [1 ]
机构
[1] Kumamoto Univ, Ctr AIDS Res, Div Clin Retrovirol & Infect Dis, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Grad Sch Sci & Technol, Dept Mat & Life Sci, Kumamoto 8600811, Japan
关键词
D O I
10.1086/339015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of neutralizing antibodies (NAbs) during virus rebound in human immunodeficiency virus type 1 (HIV-1)-infected patients undergoing highly active antiretroviral therapy is poorly understood. Three patients in this study had NAbs to preexisting autologous HIV-1 and an episode of virus rebound after a prolonged period of virus suppression. To investigate the influence of NAbs on virus evolution, envelope genotypes of preexisting and rebound viruses were examined. Phylogenetic analysis of env (V1-V5) sequences indicated that rebound viruses had evolved from or preexisted in baseline populations. By use of envelope pseudotype viruses, rebound viruses were found to be significantly resistant to neutralization by autologous antibody in all 3 patients, indicating that rebound viruses were selected by NAbs. The site responsible for conferring neutralization resistance against autologous antibody was identified in the upstream C3 region in 2 of 3 patients.
引用
收藏
页码:608 / 617
页数:10
相关论文
共 34 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]  
ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
[3]   SIMIAN IMMUNODEFICIENCY VIRUS MUTANTS RESISTANT TO SERUM NEUTRALIZATION ARISE DURING PERSISTENT INFECTION OF RHESUS-MONKEYS [J].
BURNS, DPW ;
COLLIGNON, C ;
DESROSIERS, RC .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4104-4113
[4]   Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage [J].
Cecilia, D ;
Kewalramani, VN ;
O'Leary, J ;
Volsky, B ;
Nyambi, P ;
Burda, S ;
Xu, S ;
Littman, DR ;
Zolla-Pazner, S .
JOURNAL OF VIROLOGY, 1998, 72 (09) :6988-6996
[5]   A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects [J].
Cecilia, D ;
Kleeberger, C ;
Muñoz, A ;
Giorgi, JV ;
Zolla-Pazner, S .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) :1365-1374
[6]   Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies [J].
Chackerian, B ;
Rudensey, LM ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7719-7727
[7]   Selection for neutralization resistance of the simian human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation [J].
Cheng-Mayer, C ;
Brown, A ;
Harouse, J ;
Luciw, PA ;
Mayer, AJ .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5294-5300
[8]   Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy [J].
Chun, TW ;
Davey, RT ;
Ostrowski, M ;
Justement, JS ;
Engel, D ;
Mullins, JI ;
Fauci, AS .
NATURE MEDICINE, 2000, 6 (07) :757-761
[9]   AIDS - Re-emergence of HIV after stopping therapy [J].
Chun, TW ;
Davey, RT ;
Engel, D ;
Lane, HC ;
Fauci, AS .
NATURE, 1999, 401 (6756) :874-875
[10]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944